Source:http://linkedlifedata.com/resource/pubmed/id/15920900
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-5-30
|
pubmed:abstractText |
In this study the effects of exposure to serum, lung and breakpoint concentrations on Streptococcus pneumoniae susceptibility to clarithromycin, azithromycin, amoxicillin/clavulanate, levofloxacin and moxifloxacin were evaluated. Development of resistance was determined by multi-step and single-step methodologies. In the first experimental set, minimum inhibitory concentrations (MICs) were determined after 10 passages on antibiotic-gradient plates and 10 passages on antibiotic-free plates. Acquisition of resistance was defined as an increase of > or = 4-fold from the starting MIC. In single-step studies, the rate of spontaneous mutations was calculated after a passage on antibiotic-containing agar plates. Azithromycin and levofloxacin gave the highest number of strains with MIC increased of at least 4 times the starting value, followed by moxifloxacin and by clarithromycin which only at the lowest concentration tested selected for resistance in 5 strains. Amoxicillin/clavulanate never displayed > or = 4-fold MIC increase. Frequencies of mutation were lower for clarithromycin and moxifloxacin than for the comparators. At lung concentrations clarithromycin had limited potential to select for resistance.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin,
http://linkedlifedata.com/resource/pubmed/chemical/Aza Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Azithromycin,
http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin,
http://linkedlifedata.com/resource/pubmed/chemical/Ofloxacin,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolines,
http://linkedlifedata.com/resource/pubmed/chemical/moxifloxacin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1120-009X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
161-8
|
pubmed:dateRevised |
2009-8-4
|
pubmed:meshHeading |
pubmed-meshheading:15920900-Amoxicillin,
pubmed-meshheading:15920900-Aza Compounds,
pubmed-meshheading:15920900-Azithromycin,
pubmed-meshheading:15920900-Clarithromycin,
pubmed-meshheading:15920900-Drug Resistance, Bacterial,
pubmed-meshheading:15920900-Humans,
pubmed-meshheading:15920900-Microbial Sensitivity Tests,
pubmed-meshheading:15920900-Ofloxacin,
pubmed-meshheading:15920900-Quinolines,
pubmed-meshheading:15920900-Sampling Studies,
pubmed-meshheading:15920900-Sensitivity and Specificity,
pubmed-meshheading:15920900-Streptococcus pneumoniae
|
pubmed:year |
2005
|
pubmed:articleTitle |
In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates.
|
pubmed:affiliation |
Laboratory of Clinical Microbiology, Dept of Clinical Sciences, L. Sacco Teaching Hospital, University of Milan. lorenzo.drago@unimi.it
|
pubmed:publicationType |
Journal Article,
Comparative Study
|